The University of Chicago Header Logo

Connection

Karen Kaul to Receptors, Interleukin-2

This is a "connection" page, showing publications Karen Kaul has written about Receptors, Interleukin-2.
Connection Strength

0.007
  1. Phase I trial of the diphtheria toxin/interleukin-2 fusion protein DAB486IL-2: efficacy in mycosis fungoides and other non-Hodgkin's lymphomas. Leuk Lymphoma. 1993 Nov; 11(5-6):369-77.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.